EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy of a novel interstitial lung disease monitoring program in breast cancer patients undergoing treatment with trastuzumab-deruxtecan

Julie Williamson iD, Kristen Kelley, Mary Beth Scholand, Christine Crossno, Shelly Hummert, Patricia Jeppson, Holly Jacobson, Saundra Buys

Breast Cancer Research and Treatment · 2025

DOI: 10.1007/s10549-024-07586-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2025. Verfasst von Julie Williamson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Trastuzumab, Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialTrastuzumabBreast NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMiddle AgedRetrospective StudiesAgedAdultTomography, X-Ray ComputedRespiratory Function TestsCamptothecinImmunoconjugates

Stichwörter der Autor:innen

Breast cancerPneumonitisPreventionProtocolToxicity monitoring

Substanzen

Trastuzumabtrastuzumab deruxtecanCamptothecinImmunoconjugates

Autor:innen und Institutionen

  • Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA.
  • Pulmonary Medicine Division, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
  • Department of Pharmacy, Huntsman Cancer Institute, Salt Lake City, UT, USA.

ORCID-Profile: Julie Williamson

Zitieren

APA

Williamson, J., Kelley, K., Scholand, M. B., Crossno, C., Hummert, S., Jeppson, P., Jacobson, H., & Buys, S. (2025). Efficacy of a novel interstitial lung disease monitoring program in breast cancer patients undergoing treatment with trastuzumab-deruxtecan. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07586-2

Vancouver

Williamson J, Kelley K, Scholand MB, Crossno C, Hummert S, Jeppson P, et al. Efficacy of a novel interstitial lung disease monitoring program in breast cancer patients undergoing treatment with trastuzumab-deruxtecan. Breast Cancer Research and Treatment. 2025. doi:10.1007/s10549-024-07586-2

BibTeX
@article{Williamson2025,
  author = {Williamson, Julie and Kelley, Kristen and Scholand, Mary Beth and Crossno, Christine and Hummert, Shelly and Jeppson, Patricia and Jacobson, Holly and Buys, Saundra},
  title = {Efficacy of a novel interstitial lung disease monitoring program in breast cancer patients undergoing treatment with trastuzumab-deruxtecan},
  journal = {Breast Cancer Research and Treatment},
  year = {2025},
  doi = {10.1007/s10549-024-07586-2}
}
Kostenlos starten →